Clinical Effect Analysis of Posterior Chamber Intraocular Lens Implantation for Correcting High Myopia and Astigmatism

Objective:To explore the corrective effect of posterior chamber intraocular lens implantation with phakic eyes in the treatment of high myopia and astigmatism.Methods:From May 2023,the hospital began to collect the case data of diagnosis and treatment of high myopia and astigmatism.By May 2024,310 cases were included,all of which were treated with posterior chamber intraocular lens implantation.The visual acuity,astigmatism and axial position of the intraocular lens were observed before and after treatment.Results:At different time points after the operation,the patient’s vision was significantly improved compared with that before the operation(P<0.05),and the vision level was equal to or greater than the best-corrected vision before the operation.At different time points after the operation,the average rotation of the intraocular lens was less than 5 degrees.Astigmatism was significantly lower than that before the operation(P<0.05).After the operation,the intraocular pressure increased in 11 cases,accounting for 3.55%,with no adverse complications such as lens turbidity,glare and obvious halo occurring.Conclusion:The posterior chamber intraocular lens implantation with phakic eyes has an ideal correction effect in the treatment of high myopia and astigmatism,which can effectively improve the vision level of patients and reduce the degree of astigmatism,and has high effectiveness and safety.

Long-term vision-threatening complications of phakic intraocular lens implantation for high myopia

AIMTo report the long-term vision-threatening complications in patients who underwent phakic intraocular lens (pIOLs) implantation for high myopia.

New Management of Angle-closure Glaucoma by Phacoemulsification with Foldable Posterior Chamber Intraocular Lens Implantation

Objective:To investigate the management of angle-closure glaucoma by phacoemulsification with foldable posterior chamber intraocular lens(PC-IOL)implantation.Design:Retrospective,noncontrolled interventional case series.Participants:In36eyes with angle-closure glaucoma(ACG),there were18eyes with primary acute angle-closure glaucoma(PACG),14eyes with primary chronic angle-closure glaucoma(PCCG),3eyes with secondary acute angle-closure glaucoma(SACG)and 1eye with secondary chronic angle-closure glaucoma(SCCG).Intervention:Phacoemulsification with posterior chamber intraocular lens implantation.Main Outcome Measures:Postoperative visual acuity,IOP,axial anterior chamber depth.Results:After a mean postoperative follow-up time of 8.81±7.45months,intraocular pressure was reduced from a preoperative mean of 23.81±17.84mmHg to a postoperative mean of 12.54±4.73mmHg(P=0.001).Mean anterior hamber depth was1.75±0.48mm preoperatively and2.29±0.38mm postoperatively(P=0.000).Best spectacle-corrected visual acuith in 36eyes ranged from0.01to0.7(20/200to20/30)postoperatively,which was better than preoperative VA ranging from hand movement to 0.4(20/50)(P=0.000).Conclusion:Phacoemulsification with posterior chamber foldable intraocular lens implantation can be a good alternative in treating angle-closure glaucoma,Eye Science 2000;16:22-28.

New Management of Malignant Glaucoma by Phacoemulsification with Posterior Chamber Foldable Intraocular Lens Implantation

Objective:To investigate the feasibility of phacoemulsification with posterior chamber foldable intraocular lens implantation in the management of malignant glaucoma. Patients and Methods:Fourteen patients with malignant glaucoma diagnosed in the Department of Glaucoma were enrolled in the study.12 patients developed malignant glaucoma after filtration surgery.1 developed after peripheral iridectomy.1 patient developed malignant glaucoma without any clear cause.Cataract phacoemulsification was performed.Posterior chamber intraocular foldable lens was implanted in 10 cases of patients.Results:All 14 patients were cured wiht normal intraocular pressure,normal anterior chamber depth and increased visual acuity.Conclusion:Phacoemulsification with posterior chamber foldable intraocular lens implantation is a good alternative in treating malignant glaucoma.

A Clinical Analysis of 120 Cases with Traumatic Cataract Treated by Extracapsular Cataract Extraction and Posterior Chamber Intraocular Lens Implantation

Extracapsular cataract extraction was performed combined with posterior chamber intraocular lens implantation on 120 inpatients (122 eyes) with traumatic cataract from 1992 to 1997. The results revealed that this combined operation can make most of them get useful visual acuity, although they were often accompanied with several comlicated eye injuries. We think the most important thing is to choose suitable opertion time, the reasonable operation method and take close followup after operation.

Membrane Formation on the Surface of Implanted Posterior Chamber Intraocular Lenses

Purpose:To study the prevention and treatment of the membrane formation on the lens surface after extracapsular cataract extraction(ECCE)with posterior chamber intraocular lens(PCIOL)implantation.Methods:We reviewed the records of 312 cataractous patients that had undergone ECCEwith PCIOLimplantation between1989and1993,Postoperatively all pa-tients were examined under slit-lamp microscopy.The membrane formation on the surface of PCIOLin pupilar area was divided into four grades.Two mem-branes of surgical removal were observed under a transmission electrom mi-croscopy.One PCIOLof surgical removal was observed under a scanning electron microscopy.Results;Of312 patients,21 had the membrane formation on the surface of the PCIOL postoperatively.The incidence of the membrane formation was6.7%.Comparisone with cases of senile cataract showed the incidence to be significantly the highest among;1.patients who had traumatic cataract(P<0.05);2.pa-tients with complicated cataract(P<0.05).Interoperatively residual lens corten and rupture of posterior capsule,interval time betwwen the first and second eye operations less than 1month are the main factors of menbrane formation.The ultrastructure in membrane and cytology on the lens surface showed that the membrane on the surface of PCIOLs is usually composed of acellular protein film and cellular elements,including macrophages.fibroblast-like cells,epithelioid cells,giant cells,fibroblasts and collagen fibrils,etc.Conclusions:The cellular response on the surface of an implanted PCIOLis a chonic foreign-body inflammatory reaction and the membrane of the surfaceof implanted PCIOL is a reactive membrane of the foreign-body.Eye Science1995;11:131-135.

Considerations in the management of single-piece intraocular lenses outside the capsular bag

AIM: To investigate the outcomes of off label singlepiece acrylic intraocular lenses(SPA-IOL) ciliary sulcus placement compared to three-piece IOL(3P-IOL). METHODS: The charts of eight consecutive eyes of patients who received sulcus-placed SPA-IOLs between 2006 and 2009 were reviewed. None of the patients underwent IOL exchange. Charts of six age-matched patients who received sulcus placed 3P-IOLs were reviewed as a control group. RESULTS: Mean follow up was 16 mo for SPA-IOL and 23 mo for 3P-IOL. Five of 8 patients in the SPA-IOL group required chronic use of IOP lowering medications at final follow up. Of these, one patient needed glaucoma implant surgery for uncontrolled IOP. One patient in the 3P-IOL group used chronic aqueous suppression pre- and postoperatively. Four of eight eyes with SPAIOL were treated with chronic topical steroids and or non-steroidal anti-inflammatory drugs for cystoid macu-la edema, chronic uveitis, pigment dispersion syndrome or a combination of the above, compared to none in the control group. Mean best-corrected visual acuity was 20/35 in the SPA-IOL group and 20/47 in the 3PIOL group.CONCLUSION: Sulcus placed SPA-IOLs are associated with increased ocular morbidity. In select cases good visual acuity may be achieved. Due to postoperative rotation of sulcus placed toric SPA-IOLs stable astigmatism correction cannot be achieved. Alternative intraocular lenses should be considered when in-the-bag placement of SPA-IOL is not possible.

Safety and visual outcomes following posterior chamber phakic intraocular lens bilensectomy

Background:To evaluate the safety,efficacy,refractive outcomes and causes for bilensectomy(phakic intraocular lens–pIOL–explantation with cataract surgery and pseudophakic intraocular lens implantation)in patients previously implanted with posterior chamber pIOLs.Methods:This multi-center retrospective study included 87 eyes of 55 patients who underwent bilensectomy for posterior chamber pIOL with a follow up time of 12 months.The uncorrected and best corrected distance visual acuities(UDVA,CDVA),endothelial cell density before and after bilensectomy were assessed,as well as the cause of bilensectomy and intra or postoperative complications.Results:There was a statistically significant improvement in uncorrected and best corrected visual acuities after bilensectomy(p=0.00).The main reason for bilensectomy was cataract development(93.1%of the cases),followed by miscalculation of lens size,and corneal edema.The endothelial cell count remained stable without a statistically significant change after surgery(p=0.67).The refractive efficacy index was 0.8,none of the patients lost lines of CDVA after surgery,73%of the patients were within±1 D(spherical equivalent)of the target refraction.Intraoperative complications were one posterior capsule rupture with the intraocular lens(IOL)implanted in the sulcus,and 3 eyes required the use of pupil expanders for adequate pupil dilation.Postoperatively,one eye developed retinal detachment.The three pIOLs models explanted were the Implantable Collamer Lens(ICL),Implantable Phakic Contact Lens(IPCL)and the Phakic Refractive Lens(PRL).Conclusions:Good safety and visual outcomes were observed 1 year after bilensectomy for posterior chamber phakic intraocular lenses(PC pIOLs).There were few intra and postoperative complications and there was no significant endothelial cell loss after the bilensectomy procedure.

Safety and visual outcomes following posterior chamber phakic intraocular lens bilensectomy

Background:To evaluate the safety,efficacy,refractive outcomes and causes for bilensectomy[phakic intraocular lens(plOL)explantation with cataract surgery and pseudophakic intraocular lens(IOL)implantation]in patients previously implanted with posterior chamber plOLs(PC plOLs).Methods:This multi-center retrospective study included 87 eyes of 55 patients who underwent bilensectomy for PC plOL with a follow-up time of 12 months.The uncorrected and corrected distance visual acuities(UDVA,CDVA),endothelial cell density before and after bilensectomy were assessed,as well as the cause of bilensectomy and intra or postoperative complications.Results:There was a statistically significant improvement in UDVA and CDVA after bilensectomy(P=0.00).The main reason for bilensectomy was cataract development(93.1%of the cases),followed by miscalculation of lens size,and corneal edema.The endothelial cell count remained stable without a statistically significant change after surgery(P=0.67).The refractive efficacy index was 0.8,none of the patients lost lines of CDVA after surgery,73%of the patients were within±1.0D(spherical equivalent)of the target refraction.Intraoperative complications were one posterior capsule rupture with the IOL implanted in the sulcus,and three eyes required the use of pupil expanders for adequate pupil dilation.Postoperatively,one eye developed retinal detachment.The three plOLs models explanted were the implantable collamer lens(ICL);implantable phakic contact lens(IPCL)and the phakic refractive lens(PRL).Conclusions:Good safety and visual outcomes were observed one year after bilensectomy for PC plOLs.There were few intra and postoperative complications and there was no significant endothelial cell loss after the bilensectomy procedure.

高度近视有晶状体眼后房型人工晶状体植入术后患者视力恢复的影响因素

目的 探讨高度近视有晶状体眼后房型人工晶状体(ICL)植入术后患者视力恢复的影响因素。方法 前瞻性研究。选取2021年5月至2023年3月郑州大学第二附属医院收治的210例(420眼)行ICL植入术的高度近视患者作为研究对象。根据术后3个月视力恢复情况将患者分为恢复良好组(最佳矫正视力恢复≥0.3 D)、恢复不良组(最佳矫正视力恢复<0.3 D)。比较两组患者基线资料,采用Logistic回归分析影响患者视力恢复的因素,采用受试者工作特征曲线(ROC)分析Logistic回归模型对高度近视患者ICL植入术后视力恢复不良的预测价值。结果 术后3个月,恢复良好组的患者共149例298眼,恢复不良组的患者共61例122眼。两组患者性别、年龄、近视年限、体重指数、学业情况比较,差异均无统计学意义(均为P>0.05)。恢复不良组患者角膜散光度<1.30 D占比(55.74%)、角膜屈光度<45 D占比(59.02%)、匹茨堡睡眠质量指数(PSQI)<7分占比(63.93%)、中央平均曲率半径[(7.82±0.27) mm],均低于恢复良好组[83.89%、81.88%、85.91%及(7.90±0.24)mm],角膜前表面中央扁平子午线曲率(k1)[(43.27±1.43)D]、角膜前表面陡峭子午线曲率(k2)[(44.84±1.53)D]、拱高[(628.49±67.28)μm]均高于恢复良好组[(42.73±1.42)D、(44.12±1.47)D、(417.56±80.14)μm],差异均有统计学意义(均为P<0.05)。Logistic回归分析结果显示,角膜散光度、角膜屈光度、k1、k2、拱高、睡眠PSQI评分均为高度近视患者ICL植入术后患者视力恢复不良的独立影响因素(均为P<0.05)。ROC曲线分析显示,Logistic回归模型预测高度近视患者ICL植入术后视力恢复不良的ROC曲线下面积为0.938(95%CI:0.896~0.966),敏感度为83.61%,特异度为91.95%(P<0.05)。结论 角膜散光度、角膜屈光度、k1、k2、拱高、睡眠PSQI评分等均可影响高度近视ICL植入术后患者视力恢复,基于上述因素构建的Logistic回归模型对ICL植入术后患者视力恢复有较高预测价值。

超声乳化联合玻璃体腔抗VEGF注药术对后发性白内障预防价值分析

目的 分析白内障手术联合玻璃体腔抗血管内皮生长因子(VEGF)治疗对后发性白内障的影响。方法 采用回顾性临床队列研究,回顾性分析2020年1月至2021年3月就诊于苏州大学附属第三医院眼科行白内障手术的患者41例(54眼)。其中,试验组23例(27眼)行白内障超声乳化吸除+人工晶体植入联合玻璃体腔抗VEGF药物注射术;对照组18例(27眼)行单纯白内障超声乳化吸除+人工晶体植入术。所有患者术后随访24个月,比较两组患者术后最佳矫正视力、后发性白内障以及其他眼部并发症的发生情况。结果 术后24个月患者的最佳矫正视力均有不同程度的提高;试验组后发性白内障的发生率明显低于对照组,差异有统计学意义(P <0.05);仅有1例试验组患者出现术后一过性眼压升高,其余患者术后眼压均正常。结论 白内障超声乳化吸除+人工晶体植入联合玻璃体腔抗VEGF药物注射术安全可靠,并可有效降低后发性白内障的发生率。

Dynamic assessment of variations in pupil diameter using swept-source anterior segment optical coherence tomography after phakic collamer lens implantation

Purpose To dynamically assess variations in pupil diameter induced by changes in brightness in myopic eyes implanted with an implantable collamer lens(ICL,STAAR Surgical)with a central port.Methods This prospective,observational single-center case series study comprised 65 eyes from 65 consecutive patients undergoing ICL implant.A modified commercially available swept-source Fourier-domain anterior segment optical coherence tomography(AS-OCT)device was used for imaging and performing dynamic pupillometry under changing light conditions before and after a mean follow-up interval of four months after surgery.Results Preoperative mean pupil size under photopic conditions was 3.38±0.64 mm;after surgery,this increased to 3.48±0.61 mm.Mean pupil size under scotopic light conditions was 5.72±0.79 mm before surgery and 5.84±0.77 mm postoperatively.The differences between preoperative and postoperative pupil diameter in miosis and mydriasis were 0.10±0.44 mm(P=0.078)and 0.12±0.58 mm(P=0.098),respectively.The scotopic pupil exceeded the optic zone of the implanted lens in 39 eyes(60%).The mean central vault value was 412±177μm under maximum miosis and 506±190μm under maximum mydriasis.We found a positive correlation between vault and differences in pupil diameter under all light conditions(P<0.05).Conclusion Dynamic AS-OCT enables a very precise determination of the pupillary diameter in the iris plane.The changes in the pupil diameter under different light conditions after the implantation of an ICL are related to the postoperative vault.

预装式疏水性丙烯酸酯类人工晶体和同轴微切口对年龄相关性白内障疗效分析

目的探讨与分析预装式疏水性丙烯酸酯类人工晶体和同轴微切口对年龄相关性白内障的疗效影响。方法选择2020年8月—2023年5月在蓝田华阳眼科医院诊治的80例年龄相关性白内障患者作为研究对象,根据随机数表法将其分为对照组和研究组,每组40例。所有手术均由同一位医师完成,都采用预装式疏水性丙烯酸酯类人工晶体植入,研究组行2.2 mm同轴透明角膜隧道微切口,对照组行3.0 mm透明角膜隧道切口,比较两组的最佳矫正、并发症发生情况、角膜散光度与前房深度变化情况。结果研究组术后1周与术后1个月的最佳矫正视力都高于对照组,差异有统计学意义(P<0.05);两组术后1个月的最高矫正视力与术后1周相比都升高,差异有统计学意义(P<0.05)。研究组术后1个月的角膜水肿、眼内炎、晶体混浊、囊膜破损等并发症发生率显著低于对照组,差异有统计学意义(P<0.05)。研究组术后1周与术后1个月的角膜散光度都低于对照组,差异有统计学意义(P<0.05);两组术后1个月的角膜散光度与术后1周相比都降低,差异有统计学意义(P<0.05)。研究组术后1周与术后1个月的前房深度都高于对照组,差异有统计学意义(P<0.05);研究组与对照组术后1个月与术后1周的前房深度比较,差异无统计学意义(P>0.05)。结论预装式疏水性丙烯酸酯类人工晶体联合同轴微切口在年龄相关性白内障患者的应用并不会影响患者的前房深度,能减少角膜散光度,提高患者的术后视力,减少并发症的发生。

A novel ophthalmic viscosurgical devicefree phakic intraocular lens implantation makes myopic surgery safer

Purpose:To assess the efficacy and safety of a novel ophthalmic viscosurgical device-free(OVD-free)method for posterior chamber phakic intraocular lens(PIOL)implantation in myopic eyes.Methods:In this retrospective cohort study,the medical records of myopic eyes that underwent PIOL(Implantable Collamer Lens,ICL)implantation for myopia correction at the Eye Hospital of Wenzhou Medical University between May 2015 and March 2017 were reviewed.A total of 49 eyes with complete data that met follow up requirements(2 h,1 day,1 week,3 months postoperatively)were recruited.Based on the surgical techniques used,the eyes were divided into the OVD-free method group and the standard method group.The clinical data,including intraocular pressure(IOP),corrected distance visual acuity(CDVA)and spherical equivalent(SE),at each follow-up were collected for comparison.Endothelial cell loss and complications were also investigated.Results:Twenty-one eyes received the standard method,and 28 eyes received the OVD-free method.A rise in IOP>22 mmHg at 2 h was noted in 14 eyes(66.7%)in the standard group and none(0%)in the OVD-free group(p<0.001).The rise in IOP from baseline was significantly higher at 2 h in the standard group(10.5±5.2 mmHg vs.2.2±3.3 mmHg,difference:8.3,95%CI 5.8 to 10.8;p<0.001).There was a significant difference in the time course of LogMAR CDVA changes between the two groups(p=0.047).The LogMAR CDVA was significantly better in the OVD-free method group compared to the standard group at 1 day(−0.076,95%CI−0.134 to−0.018;p=0.012),1 week(−0.071,95%CI−0.135 to−0.007;p=0.03),but not at 3 months(−0.046,95%CI−0.107 to 0.015;p=0.134).There was no significant difference in the time course of SE changes between the two groups(p=0.471;p=0.705).In the OVD-free group,mean endothelial cell loss was 4.6%at 3 months(2522±281 vs.2407±226 cells/mm^(2),difference:-115,95%CI−295 to 65;p=0.187).No complications were reported in both groups except for the early IOP elevation in the standard group during the observation period.Conclusions:The OVD-free method is safe and efficient for ICL implantation.It can be a safer method of ICL implantation compared to the standard method in that it completely eliminates ophthalmic viscoelastic devicesrelated complications without causing additional complications.

ICL植入术后拱高大于1000μm的中高度近视患者疗效观察

目的:观察有晶状体眼后房型人工晶状体(ICL)植入术后拱高大于1000μm的中高度近视患者的疗效。方法:回顾性研究。选择2014-01/2017-01在我院接受ICL植入术且术后拱高大于1000μm的中高度近视患者42例73眼。比较患者术前及术后1、3、6mo,1a以及末次随访时的视力、眼压、角膜内皮细胞密度、前房相关参数(房角、中央前房深度和前房容积)以及拱高的变化情况。结果:术后1、3、6mo,1a以及末次随访时的裸眼视力(UCVA)均优于术前(均P<0.05),房角、中央前房深度和前房容积均低于术前(均P<0.05),但术后各时间点的UCVA、房角、中央前房深度和前房容积比较均无差异(均P>0.05)。术后1mo时眼压低于术前(P<0.05),但术后3、6mo,1a以及末次随访时的眼压与术前比较均无差异(均P>0.05)。术后1、3、6mo,1a以及末次随访时的角膜内皮细胞密度与术前比较均无差异(均P>0.05)。术后1、3、6mo,1a以及末次随访时的拱高呈逐渐降低趋势,术后各时间点拱高比较均有差异(均P<0.05)。结论:ICL植入术后拱高大于1000μm的中高度近视患者的近远期疗效较好,对患者眼压、角膜内皮细胞无明显影响,术后前房结构较稳定,且拱高随时间推移呈下降趋势,密切观察即可,一般不需要更换。

20G灌注头辅助下无粘弹剂植入V4c-ICL矫正对高度近视早期调节功能的影响

目的:探讨20G灌注头辅助下无粘弹剂植入有晶状体眼后房型人工晶状体(V4c-ICL)对高度近视(HM)患者早期调节功能的影响。方法:选取HM患者493例(986眼)作为研究对象,按手术方式不同分为V4c-ICL植入术组(研究组,n=247)和全飞秒小切口基质透镜取出术(SMILE)组(对照组,n=246)。随访两组患者术前、术后1个月视力[裸眼视力(UDVA)、最佳矫正视力(BCVA)]、眼压、调节功能[正负相对调节(PRA/NRA)、单眼调节幅度(M-AMP)、远近水平隐斜、调节性集合与调节比值(AC/A)],行国家眼科研究所视功能问卷-25(NEI-VFQ-25)评分,记录并发症情况。结果:术后1个月,两组患者UDVA、BCVA均较术前升高,眼压降低(P<0.05),但两组间比较,差异无统计学意义(P>0.05);两组PRA、远近水平隐斜、AC/A比值较术前降低,M-AMP升高,其中研究组PRA、远水平隐斜、AC/A比值低于对照组,M-AMP高于对照组(P<0.05);两组NEI-VFQ-25评分均较术前升高(P<0.05),其中研究组除色觉(CV)维度外,其余各维度评分均高于对照组(P<0.05)。两组并发症总发生率比较,差异无统计学意义(P>0.05)。结论:SMILE与20G灌注头辅助下无粘弹剂下V4c-ICL矫治HM均可获得良好的术后视力,但相比SMILE,无粘弹剂下V4c-ICL可获得更好的双眼调节功能,改善患者视觉相关生活质量,值得临床优先选择。

超高度近视眼行有晶状体眼人工晶体植入术前后视网膜和脉络膜厚度及血流参数变化

目的通过光学相干断层扫描血管成像技术(OCTA)观察超高度近视眼行中央有孔型有晶状体眼后房型人工晶体前植入术(ICL-V4c)前后视网膜和脉络膜厚度、黄斑区及视盘旁视网膜血流密度的变化。方法选取2020年4月-2021年5月于首都医科大学附属北京同仁医院就诊且双眼等效球镜度(SE)≥±10.0 D的患者15例(30眼),所有眼均行ICL-V4c治疗。观察并比较患者术前及术后2 h、1周、1个月、9个月时视力、眼压的变化,并采用OCTA监测黄斑区视网膜和脉络膜厚度、黄斑区及视盘旁视网膜血流密度的变化。结果患者术后各时间点裸眼视力与术前最佳矫正视力比较差异无统计学意义(P>0.05);术后眼压呈下降趋势,但与术前比较差异无统计学意义(P>0.05);术后9个月拱高较术后1周降低,差异有统计学意义(P=0.002)。手术前后各时间点深层视网膜血流密度、黄斑区视网膜厚度、黄斑区脉络膜厚度、视盘旁放射状毛细血管网血流密度、神经纤维层厚度差异均无统计学意义(P>0.05),而术后2 h时,上下鼻颞4个方向的浅层视网膜血流密度均较术前明显下降,差异有统计学意义(P<0.05)。术后其余时间点各区域血流密度与术前比较差异均无统计学意义(P>0.05)。结论超高度近视眼行ICL-V4c植入术早期对浅层视网膜血流密度有影响,随时间延长可恢复至术前水平,对于黄斑部视网膜脉络膜厚度及深层视网膜血流密度、视盘旁毛细血管网血流密度和神经纤维层厚度无影响。

优化ICL V4c植入术的临床研究进展

随着有晶状体眼后房型人工晶状体植入术的发展及可植入式接触镜(ICL)的不断改进,ICL V4c植入术目前已经成为矫正中高度近视的主流术式之一。术后拱高是评价手术安全性的重要指标,在常规ICL V4c植入手术的基础上,如何优化手术以获得更理想的拱高是近年来学者们研究的热点。本文以术前检查、术中手术设计以及术后随访为中心,总结分析优化ICL V4c植入手术的方案,为提高手术安全性提供帮助。

有晶状体眼后房型人工晶状体植入术术前检查操作规范专家共识(2023)

目前有晶状体眼后房型人工晶状体植入术临床应用广泛, 其安全性、有效性和稳定性已被临床验证。作为眼内手术, 术中和术后可能存在潜在风险。术前检查是避免出现并发症, 保证手术安全的重要保障。本专家共识依据国内外的重要文献及循证医学证据对术前检查提出推荐意见, 即除了常规的眼部查体外, 还需进行如下检查:主导眼、屈光度检查、角膜厚度、角膜曲率、角膜水平白到白间距、睫状沟直径、前房深度、晶状体厚度及矢高、瞳孔直径及暗瞳的测量。由于屈光手术患者对术后效果及视觉质量要求较高, 因此, 有条件单位可根据患者情况做以下眼部检查:视觉质量相关检查、干眼相关检查、视功能相关检查。本共识旨在规范有晶状体眼后房型人工晶状体植入术的术前检查, 以期为该领域开展此项手术的眼科医师提供参考和帮助。

PC-PRL植入术治疗超高度近视的研究进展

有晶状体眼后房型人工晶状体植入术是在后房植入有屈光力的人工晶状体来矫正屈光不正,其有效性、安全性、稳定性和可预测性高。依镜—有晶状体眼后房屈光晶状体(PC-PRL)是一种悬浮型人工晶状体,具有良好视觉效果、调节可得到维持、安全、可逆等优势,成为大多数高度、超高度近视患者的选择,术后的疗效受到越来多人的关注。此文就手术优势、晶状体的设计、术后的视力、屈光度、拱高、眼压、角膜内皮细胞计数、视觉质量及光学结果等方面作一概述。